Table 1.

Baseline patient characteristics (N = 26)

n (%)
Age, y
    Median (range)49 (29–67)
Size of tumor (cm; clinical)
    ≤2.02 (7.7)
    2.1-5.018 (69.2)
    ≥5.16 (23.1)
Prechemotherapy lymph node status (includes SLNB)
    Negative6 (23.1)
    Positive20 (76.9)
Prechemotherapy stage (includes SLNB)
    I0 (0)
    II19 (73.1)
    III7 (26.9)
Hormone receptor status
    ER+/PgR+7 (26.9)
    ER−/PgR−15 (57.7)
    ER+/PgR−2 (7.7)
    ER−/PgR+2 (7.7)
Her-2/neu Status (positive required 3+ by IHC or FISH+)
    Negative20 (76.9)
    Positive6 (23.1)
  • Abbreviations: SLNB, sentinel lymph node biopsy; ER, estrogen receptor; PgR, progesterone receptor; IHC, immunohistochemistry; FISH, fluorescence in situ hybridization.